A Noninvasive Method to Sample Immune Cells in the Lower Female Genital Tract Using Menstrual Discs.


Journal

ImmunoHorizons
ISSN: 2573-7732
Titre abrégé: Immunohorizons
Pays: United States
ID NLM: 101708159

Informations de publication

Date de publication:
01 Feb 2024
Historique:
received: 21 11 2023
accepted: 06 02 2024
medline: 22 2 2024
pubmed: 22 2 2024
entrez: 22 2 2024
Statut: ppublish

Résumé

T cells in the human female genital tract (FGT) are key mediators of susceptibility to and protection from infection, including HIV and other sexually transmitted infections. There is a critical need for increased understanding of the distribution and activation of T cell populations in the FGT, but current sampling methods require a healthcare provider and are expensive, limiting the ability to study these populations longitudinally. To address these challenges, we have developed a method to sample immune cells from the FGT utilizing disposable menstrual discs which are noninvasive, self-applied, and low in cost. To demonstrate reproducibility, we sampled the cervicovaginal fluid of healthy, reproductive-aged individuals using menstrual discs across 3 sequential days. Cervicovaginal fluid was processed for cervicovaginal cells, and high-parameter flow cytometry was used to characterize immune populations. We identified large numbers of live, CD45+ leukocytes, as well as distinct populations of T cells and B cells. Within the T cell compartment, activation and suppression status of T cell subsets were consistent with previous studies of the FGT utilizing current approaches, including identification of both tissue-resident and migratory populations. In addition, the T cell population structure was highly conserved across days within individuals but divergent across individuals. Our approach to sample immune cells in the FGT with menstrual discs will decrease barriers to participation and empower longitudinal sampling in future research studies.

Identifiants

pubmed: 38386594
pii: 266705
doi: 10.4049/immunohorizons.2300105
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

182-192

Informations de copyright

Copyright © 2024 The Authors.

Auteurs

M Quinn Peters (MQ)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA.

Eva Domenjo-Vila (E)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.

Marc Carlson (M)

Research Scientific Computing, Enterprise Analytics, Seattle Children's Research Institute, Seattle, WA.

Blair Armistead (B)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA.

Paul T Edlefsen (PT)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.

Melanie Gasper (M)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA.

Smritee Dabee (S)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA.

Christopher Whidbey (C)

Department of Chemistry, Seattle University, Seattle, WA.

Heather B Jaspan (HB)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA.
Department of Pediatrics, University of Washington, Seattle, WA.
Department of Global Health, University of Washington, Seattle, WA.

Martin Prlic (M)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.
Department of Global Health, University of Washington, Seattle, WA.
Department of Immunology, University of Washington, Seattle, WA.

Whitney E Harrington (WE)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA.
Department of Pediatrics, University of Washington, Seattle, WA.
Department of Global Health, University of Washington, Seattle, WA.

Classifications MeSH